1186240-99-2

Upstream product

• 88-75-5 2-hydroxynitrobenzene 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 21407-49-8 2-nitrophenyl glycidyl ether 
• 61396-67-6 rac-3-(2-nitrophenoxy)-1,2-propanediol 
• 1186240-98-1 C₁₅H₂₅NO₅Si 

Downstream Products

• 1186241-04-2 2-[[4-[(4-Methoxy-2,6-dimethyl-phenyl)sulfonyl]-3,4-dihydro-2H-[1,4]benzoxazin-3-yl]-methoxy]-acetic acid 
• 1186241-06-4 C₁₆H₁₆ClNO₄S 
• 1186241-02-0 C₁₈H₂₁NO₅S 
• 1186241-07-5 C₂₂H₂₆ClNO₆S 
• 1186241-05-3 C₂₂H₃₀ClNO₄SSi 
• 1186241-03-1 C₂₄H₃₁NO₇S 
• 1186241-01-9 C₂₄H₃₅NO₅SSi 
• 1186240-87-8 N-((1-(2-((4-(4-methoxy-2,6-dimethylphenylsulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-3-yl)methoxy)acetyl)-4-(4-methylpiperazin-1-yl)piperidin-4-yl)methyl)isonicotinamide 
• 1187964-52-8 C₂₂H₂₈F₃NO₄SSi 
• 1187964-01-7 C₂₂H₂₄F₃NO₆S 
• 1187964-00-6 C₁₆H₁₄F₃NO₄S 
• 1187964-02-8 2-[[4-[[2-(Trifluoromethyl)-phenyl]sulfonyl]-3,4-dihydro-2H-[1,4]benzoxazin-3-yl]-methoxy]-acetic acid 

Relevant academic research and scientific papers

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

SUBSTITUTED SULFONAMIDE COMPOUNDS

Substituted sulfonamide compounds corresponding to formula I processes for the preparation thereof, pharmaceutical compositions containing these compounds, and the use of such substituted sulfonamide compounds in pharmaceutical compositions for the treatment and/or inhibition of pain and other conditions at least partly mediated by the bradykinin 1 receptor

Substituted Sulfonamide Compounds

Substituted sulfonamide compounds corresponding to formula I: a process for their preparation, pharmaceutical compositions comprising such compounds, and the use of such substituted sulfonamide compounds in pharmaceutical compositions for the treatment of pain or other disorders or diseases that are mediated at least in part by B1R receptors.

Substituted Sulfonamide Compounds

Substituted sulfonamide compounds corresponding to the formula I: processes for the preparation thereof, pharmaceutical composition containing these compounds and the use of substituted sulfonamide compounds for the preparation of pharmaceutical compositions.